How to Rein in Big Tech’s Secret Data Center Deals
November 2025 — This brief explains how Big Tech’s building spree will place new strains and costs on local communities, while providing questionable benefits to residents and taxpayers, all under a corrupt regime of secret agreements that excludes the public from participating in any debate. But, as this policy brief describes, there are several steps state and local lawmakers can take to bring these secret deals to light and provide more transparency and accountability to Big Tech’s actions in their communities.
The New Railroad Barons: Why the Union Pacific/Norfolk Southern Railroad Merger Must Be Blocked
October 20, 2025 — This brief explains the proposed acquisition in the context of the modern railroad industry, the dangers of any such combination, the stakeholders likely to be most affected, and how the public can push back against this merger. It also outlines the regulatory process and merger rules of the Surface Transportation Board (STB), the federal agency with merger review authority over the railroad industry. An appendix outlines the STB’s regulatory process and review timeline for the deal.
Morgan’s Monopoly Digest – Oct 2025
October, 2025 — July version of Economic Liberties' monthly newsletter that covers the latest with the federal antitrust agencies — the Federal Trade Commission and the Department of Justice's Antitrust Division — and other big developments in competition policy.
A Kick in the Teeth: How Consolidation Endangers Independent Dentists
October 1, 2025 — This brief explores consolidation in dental insurance and practices, its harms to patients and providers, and offers policy recommendations.
William J. McGee’s Testimony at Senate Antitrust Subcommittee Hearing, “Examining Competition in America’s Skies”
September 30, 2025 — William J. McGee, Senior Fellow for Aviation and Travel at the American Economic Liberties Project, testifies in the Senate Judiciary Subcommittee on Antitrust, Competition Policy, and Consumer Rights for a hearing on "Examining Competition in America's Skies."
The Penny Price Pharmacy Toolkit: How Local Government Can Leverage the Federal 340B Program to Lower Out-of-Pocket Prescription Drug Costs
August 2025 — This toolkit explains how local lawmakers can leverage an obscure federal drug-pricing program, called 340B, that allows safety-net health care providers — often publicly owned — to purchase prescription drugs at special low prices, including the underlying legal authority.